Immunoglobulin plus Cyclosporine for Prevention of Coronary Artery Abnormalities in Kawasaki Disease

Although combined therapy led to lower incidence of coronary artery abnormalities, important caveats may limit the findings’ relevance.

Source link

Related posts

Everlywell Utilizes Telemedicine and At-Home Lab Testing to Diagnose COVID-19


Butterfly Network Expands Applications for Smartphone-Connected Ultrasound: Interview


CDC: Number of Vaping-Linked Lung Illnesses Up to 2,172


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World